Journal of Clinical Medicine Article EUS-Guided Versus Percutaneous Celiac Neurolysis for the Management of Intractable Pain Due to Unresectable Pancreatic Cancer: A Randomized Clinical Trial 1, 2, , 3, 4 5 Won Jae Yoon y, Yul Oh y z, Changhoon Yoo y , Sunguk Jang , Seong-Sik Cho , 2,§ 2, , 6, , Jeong-Hun Suh , Seong-Soo Choi * k and Do Hyun Park * k 1 Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul 07804, Korea;
[email protected] 2 Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea;
[email protected] (Y.O.);
[email protected] (J.-H.S.) 3 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea;
[email protected] 4 Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH 44195, USA;
[email protected] 5 Department of Occupational and Environmental Medicine, College of Medicine, Dong-A University, Busan 49201, Korea;
[email protected] 6 Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea * Correspondence:
[email protected] (S.-S.C.);
[email protected] (D.H.P.) Yoon, Oh, and Yoo contributed equally to this paper. y This author is now with the Namyangju Baek Hospital, Namyangju-si, Korea. z § This author is now with the Seoulnanum Pain Clinic, Jeju-si, Korea. Park and Choi contributed equally to this paper as corresponding authors. k Received: 26 April 2020; Accepted: 28 May 2020; Published: 1 June 2020 Abstract: Although endoscopic ultrasound-guided celiac neurolysis (EUS-CN) and percutaneous celiac neurolysis (PCN) are utilized to manage intractable pain in pancreatic cancer patients, no direct comparison has been made between the two methods.